Abstract
Joseph Jebelli John Murray, 2017 , HB, 320 pp, £18.99, 978-1473635739 Joseph Jebelli is a researcher at the Institute of Neurology at University College London, working on rats genetically programmed to develop Alzheimer’s disease — specifically, on immune stimulation of microglial cells in the hope that this will make some contribution to an eventual cure. He begins with an account of the first formal description of the disease by Alois Alzheimer in 1906, whose presentation to a psychiatric convention was met with a distinctly uninterested response from his psychoanalytically inclined audience. His work was rewarded in 1910 when Kraepelin, in his Handbook of Psychiatry , used the term ‘Alzheimer’s disease’ for the first time. Moving on to describe the major research findings to …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
